Your browser doesn't support javascript.
loading
A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution.
Piddock, Laura J V; Paccaud, Jean-Pierre; O'Brien, Seamus; Childs, Michelle; Malpani, Rohit; Balasegaram, Manica.
  • Piddock LJV; Global Antibiotic Research and Development Partnership (GARDP), Geneva, Switzerland.
  • Paccaud JP; Global Antibiotic Research and Development Partnership (GARDP), Geneva, Switzerland.
  • O'Brien S; Global Antibiotic Research and Development Partnership (GARDP), Geneva, Switzerland.
  • Childs M; Global Antibiotic Research and Development Partnership (GARDP), Geneva, Switzerland.
  • Malpani R; Global Antibiotic Research and Development Partnership (GARDP), Geneva, Switzerland.
  • Balasegaram M; Global Antibiotic Research and Development Partnership (GARDP), Geneva, Switzerland.
Clin Infect Dis ; 74(10): 1866-1871, 2022 05 30.
Article en En | MEDLINE | ID: mdl-34618892
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Farmacorresistencia Bacteriana / Antibacterianos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Farmacorresistencia Bacteriana / Antibacterianos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article